These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28340565)

  • 1. u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression.
    Ciavarella S; Laurenzana A; De Summa S; Pilato B; Chillà A; Lacalamita R; Minoia C; Margheri F; Iacobazzi A; Rana A; Merchionne F; Fibbi G; Del Rosso M; Guarini A; Tommasi S; Serratì S
    BMC Cancer; 2017 Mar; 17(1):215. PubMed ID: 28340565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynold LM
    Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
    Kanemaru A; Yamamoto K; Kawaguchi M; Fukushima T; Lin CY; Johnson MD; Camerer E; Kataoka H
    Int J Cancer; 2017 Jan; 140(1):130-141. PubMed ID: 27615543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system.
    Killeen SD; Wang JH; Andrews EJ; Redmond HP
    Br J Cancer; 2009 May; 100(10):1589-602. PubMed ID: 19436306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
    Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
    Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.
    Nieves EC; Manchanda N
    J Biol Chem; 2010 Apr; 285(17):12595-603. PubMed ID: 20177061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
    Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the effect of TF/FVIIa complex on the expression of u-PAR mRNA in human ovarian cancer].
    Fang J; Wei WN; Xia LH; Song SJ
    Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):143-6. PubMed ID: 15182581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
    Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
    Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
    Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
    Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
    Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
    Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R; Torà M; Díaz VM; Real FX
    Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression.
    Zheng B; Ohuchida K; Chijiiwa Y; Zhao M; Mizuuchi Y; Cui L; Horioka K; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M; Tanaka M
    Mol Carcinog; 2016 Nov; 55(11):1560-1572. PubMed ID: 26373617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
    Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
    Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC
    Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
    Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
    Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
    Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
    Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
    Mirshahi SS; Lounes KC; Lu H; Pujade-Lauraine E; Mishal Z; Bénard J; Bernadou A; Soria C; Soria J
    FEBS Lett; 1997 Jul; 411(2-3):322-6. PubMed ID: 9271229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.
    Shiomi H; Eguchi Y; Tani T; Kodama M; Hattori T
    Am J Pathol; 2000 Feb; 156(2):567-75. PubMed ID: 10666386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.